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Abstract
The Sprouty (Spry) family of proteins represents endogenous regulators of downstream signaling pathways induced by
receptor tyrosine kinases (RTKs). Using real time PCR, we detect a significant increase in the expression of Spry4 mRNA in
response to NGF, indicating that Spry4 could modulate intracellular signaling pathways and biological processes induced by
NGF and its receptor TrkA. In this work, we demonstrate that overexpression of wild-type Spry4 causes a significant
reduction in MAPK and Rac1 activation and neurite outgrowth induced by NGF. At molecular level, our findings indicate that
ectopic expression of a mutated form of Spry4 (Y53A), in which a conserved tyrosine residue was replaced, fail to block both
TrkA-mediated Erk/MAPK activation and neurite outgrowth induced by NGF, suggesting that an intact tyrosine 53 site is
required for the inhibitory effect of Spry4 on NGF signaling. Downregulation of Spry4 using small interference RNA
knockdown experiments potentiates PC12 cell differentiation and MAPK activation in response to NGF. Together, these
findings establish a new physiological mechanism through which Spry4 regulates neurite outgrowth reducing not only the
MAPK pathway but also restricting Rac1 activation in response to NGF.
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Introduction
The best-characterized member of the neurotrophins is nerve
growth factor (NGF), which supports the differentiation and
survival of specific populations of sensory, sympathetic, and central
nervous system neurons via the activation of its receptor tyrosine
kinase, TrkA. Once activated, TrkA receptors trigger intracellular
signal transduction cascades, including those mediated by Ras/
Mitogen-Activated Protein Kinase (MAPK), PI3-kinase (PI3K)/
Akt, PLC and other pathways regulated by Rho family of small
GTPases. Activation of these pathways allows NGF to regulate
neuronal differentiation and survival [1,2]. At the same time,
receptor tyrosine kinases also trigger a complex chain of molecular
events, named negative signaling, that reduce the strength and
duration of positive signals to finally modulate the cellular
physiology. Previous studies have revealed that receptor tyrosine
kinase signaling is tightly regulated through the coordinated action
of several protein inhibitors that function at multiple levels of the
signaling cascade and at different time-points after receptor
engagement [3]. While positive signaling effectors are relatively
well understood, signaling attenuation still remains elusive [3,4].
During the last years, the Sprouty (Spry) family of proteins
(Sprouty1–4) has emerged as negative signaling regulators of many
trophic factors [5]. Sprouty was first described as an inhibitor of
fibroblast growth factor (FGF)-stimulated tracheal branching
during Drosophila development [6]. Subsequent studies revealed
that mammalian genome contain four Sprouty genes encoding
proteins of 32–34 kDa. It has been reported that trophic factors
regulate the activity of Sprouty inducing its expression and
promoting the phosphorylation of Sprouty proteins on critical
tyrosine residues [5].
The emerging picture from Sprouty’s studies indicates that they
specifically inhibit Ras-Raf-MAPK pathway activated by a wide
range of trophic factors, including FGF [6,7], BDNF (Brain-
Derived Neurotrophic Factor) [8], GDNF (Glial cell line-Derived
Neurotrophic Factor) [9], PDGF (Platelet-Derived Growth Factor)
[10] and VEGF (Vascular Epithelial Growth Factor) [11], but do
not affect MAPK activated by EGF (Epidermal Growth Factor)
[12]. The molecular mechanism through which Sprouty antago-
nizes MAPK remains unclear, and may depend on the cellular
context or the RTK involved. Interestingly, Sprouty2 was reported
to potentiate biological effects induced by EGF, inhibiting
epidermal growth factor receptor ubiquitination and downregu-
lation [13–15]. These findings suggest that the role of Sprouty in
RTK signaling is still controversial, because they may regulate
RTK signaling in a negative or positive manner.
The regulation of neuronal physiology and the development of
the nervous system require a tight spatial and temporal control,
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expression of inhibitory proteins that counteract neurotrophic
factor receptor signaling. Despite of the essential contribution of
NGF for neuronal development and function, the molecular
mechanisms that control NGF-induced TrkA signaling are not
totally understood. Previous work has shown that expression of
Sprotuy4, but not Sprouty1 or 2, could be induced after NGF
treatment of PC12 neuronal cells [10,12]. However, despite this
evidence, the functional contribution of Sprouty4 to NGF
signaling and biology has not been explored, yet. In view of this,
we decided to investigate whether Sprouty4 might play a
prominent role controlling TrkA signaling and biological responses
to NGF.
In this study, we determine that Sprouty4 is a TrkA-induced
gene that restricts Erk/MAPK pathway and inhibits Rac1, but not
Akt, activation in response to NGF. At the molecular level, we
identify the Tyr-53 of Sprouty4 as an essential determinant for this
inhibitory activity. Here, we also show that Sprouty4 negatively
regulates NGF-induced neuronal differentiation of PC12 cells and
primary sensory neurons.
Results
NGF induces Sprouty4 expression in neuronal cells
Recent studies on the mechanisms that restrict RTK signaling
revealed the importance of negative-feedback control of receptor
function as a mechanism to ensure signaling thresholds
compatible with a physiological response. Based on this concept,
we analyzed whether Spry4 is induced on neuronal cells after
NGF stimulation. Using real-time PCR, we examined the
expression pattern of Spry4 mRNA in PC12 cells in response to
NGF. This quantitative analysis revealed a significant induction
of Spry4 mRNA in this neuronal cell line responsive to NGF
(Fig. 1A, left panel). The Spry4 mRNA induction was additionally
observed by semiquantitative RT-PCR (Supplementary Fig. S1).
In contrast, neither Spry1 nor Spry2 mRNAs were detected by
RT-PCR in PC12 cells in the absence or presence of NGF
(Fig. 1A, right panel). Spry4 protein up-regulation was addition-
ally confirmed by immunoblotting of PC12 cell lysates treated
with NGF (Fig. 1B).
Previous work showed that Erk/MAPK activation pathway by
mitogenic stimuli induces Spry4 in cultured cells [12]. To examine
this possibility, PC12 cells were incubated in the presence or
absence of a specific inhibitor of Erk/MAPK pathway, PD98059,
before stimulation with NGF. The mRNA level of Spry4 was
determined by semiquantitative RT-PCR from samples prepared
4 h after ligand stimulation, and compared with cells that were not
treated with PD98059. As shown in Figure 1C, left panel,
pharmacological inhibition of the MAPK pathway with PD98059,
abrogated the NGF-induced Spry4 mRNA expression, suggesting
that an intact MAPK pathway is required for Spry4 up-regulation
in response to NGF. The inhibitory activity of PD98059 was
controlled in parallel, measuring MAPK activation by immuno-
blotting of PC12 cell extracts stimulated for 10 min with NGF
(Fig. 1C, right panel).
To address whether Spry4 may play a physiological role in
NGF/TrkA-driven dorsal root ganglion (DRG) neuron develop-
ment, we examined whether Spry4 and the NGF receptor, TrkA,
are co-expressed in DRG neurons, a neuronal subpopulation
highly responsive to NGF. Primary dissociated DRG neurons
obtained from E14.5 rats were assessed by immunofluorescence
using anti-Spry4 and anti-TrkA antibodies. The staining revealed
a striking co-localization of Spry4 and TrkA expression in DRG
neurons (Fig. 1D).
Using real-time PCR, we examined the pattern of mRNA
expression of Spry1, Spry2 and Spry4 in response to NGF in primary
DRG neurons. In these experiments, we only detected a significant
increase in the expression of Spry4 mRNA in response to NGF
(Fig. 1E). Thus, the specific induction of Spry4 mRNA detected in
DRG neuronal cultures treated with NGF indicates that Spry4
may play a physiological role in NGF/TrkA-driven DRG neuron
development and function.
Sprouty4 specifically inhibits NGF-induced Erk/MAPK and
Rac1 activation
To establish whether Spry4 could modulate NGF/TrkA
signaling, we investigated its role on different intracellular
signaling pathways induced by NGF. TrkA receptors transmit
intracellular signals through several of the canonical pathways
activated by other RTKs, including the Ras/MAP kinase, PI3K/
Akt, PLC and other signaling pathways controlled by Rac1
GTPases. To determine whether Spry4 could regulate the Erk/
MAPK pathway downstream of TrkA, we transiently transfected
HA-tagged Erk2/MAPK plasmid with control or Myc-tagged
Spry4 vector into PC12 cells. After 36 h, cells were serum-starved
and stimulated with or without NGF for 10 min. The level of Erk2
activation was evaluated by HA-immunoprecipitation followed by
immunoblotting with a specific antibody against phosphorylated
Erk1 and Erk2/MAPK. PC12 cells expressing Spry4 showed a
significant reduction in Erk2/MAPK activation compared to
control cells (Fig. 2A and 2B). Similar results were obtained by
comparing NGF-dependent endogenous MAPK activation in
lysates prepared from parental PC12 cells and clones overexpress-
ing Spry4 (PC12-Spry4 cells) (Fig. 2C). On the contrary, Spry4
could not reduce NGF-induced Akt activation in response to NGF
in the same clones (Fig. 2D).
In order to explore at which level Spry4 could restrict MAPK
activation, we co-expressed a constitutively active V12-Ras
together with Spry4 in PC12 cells. In this experiment Spry4 was
able to reduce ligand-independent MAPK activation by constitu-
tively active V12-Ras, indicating that Spry4 impairs MAPK
activation acting downstream Ras (Fig. 2E).
Rho-like GTPases, including RhoA, Rac1 and Cdc42 are
critical proteins in transducing neurotrophin signals to the actin
cytoskeleton [16]. In particular, it has been described that neurite
outgrowth induced by NGF/TrkA is mediated by Rac1 activation
[17,18]. Since Spry2 has previously been reported to regulate cell
migration of rat intestinal epithelial cells by specifically inhibiting
the activation of Rac1, but not Cdc42 GTPases [19], we evaluated
whether Spry4 could regulate NGF-induced Rac1 activation in
PC12 and PC12-Spry4 cells stimulated with NGF (Fig. 3A). The
level of active Rac1 (Rac1-GTP) was measured by using an
affinity-precipitation assay with the GST-tagged Rac1-GTP
interacting binding domain of Pak. As it has been previously
described, Rac1 was activated in PC12 cells after 10 min of NGF
stimulation. However, the activity of Rac1 was significantly
reduced in PC12-Spry4 cells, indicating that Spry4 negatively
regulates Rac1 activation triggered by NGF (Fig. 3A and 3B, and
Supplementary Fig. S2). Indeed, the specific co-immunoprecipi-
tation between endogenous Rac1 and Myc-tagged Spry4 reported
in Fig. 3C, suggests that these two molecules might directly
associate and additionally support its functional interaction.
Sprouty4 inhibits neuronal differentiation of PC12 cells
and DRG neurons in response to NGF
As it is known that TrkA signaling contributes to NGF-mediated
survival and differentiation of various neuronal populations, we
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growth of neuroblast-like PC12 cells in response to NGF. For this
purpose, PC12 cells were transfected with control or Myc-tagged
Spry4 plasmid in combination with an enhanced green fluorescent
protein (GFP) expression vector. Cells were maintained in the
presence of NGF for 72 h and stained with anti-myc antibodies to
confirm that all GFP-positive cells express Spry4. To exclude the
possibility that the effects seen overexpressing Spry4 were due to
apoptosis, the morphology of the nuclei was controlled using the
nuclear staining DAPI. Interestingly, overexpression of Spry4
inhibited NGF-induced PC12 neurite outgrowth. A significant
reduction in cells bearing neurites was observed after transfection
with Myc-tagged Spry4 plasmid (Fig. 4A and 4B, and Supple-
mentary Fig. S3). This result demonstrates that Spry4 restricts
NGF-mediated morphological differentiation of PC12 neuronal
cells.
In agreement with the control of Rac1 activity by Spry4
described above (Fig. 3), ectopic expression of a dominant
Figure 1. NGF signaling induces Sprouty4 in neuronal cells. A) Left panel, quantitative analysis of Sprouty4 mRNA expression by real-time PCR
in PC12 cells treated with NGF (50 ng/ml) during the indicated times. The levels of Sprouty4 (Spry4) mRNA were normalized using the expression of
the housekeeping gene Tbp (TATA binding protein). Shown are averages 6 SD of triplicate determinations. *p,0.001 versus control (Ctrl) group
(one-way ANOVA followed by Dunnett’s test). Right panel, expression of Spry1 and Spry2 mRNAs examined by RT-PCR (35 cycles) in DRG and PC12
cells treated with NGF (50 ng/ml) for different time-points. Expression of the housekeeping gene Tbp was used as loading control. The experiment
was repeated two times with similar results. B) Western blot analysis of Sprouty4 expression in PC12 cells treated with NGF (50 ng/ml). Reprobing
control was done with antibodies against -tubulin. Fold change relative to -tubulin is indicated. C) Left panel, expression of Spry4 mRNA examined by
semiquantitative RT-PCR (27 cycles) in PC12 cells treated with the specific MEK inhibitor PD98059 (50 M) and stimulated with NGF (50 ng/ml) as
indicated. Expression of the housekeeping gene Tbp was used as loading control. Right panel shows a control experiment performed in parallel to
verify the inhibitory activity of PD98059 on MAPK pathway. PD98059 activity was controlled measuring MAPK activation by immunoblotting of PC12
cells stimulated for 10 min with NGF (50 ng/ml). Reprobing control was done with antibodies against -tubulin. D) Colocalization of Sprouty4 and TrkA
in DRG dissociated neurons obtained from E14.5 rat embryos detected by immunofluorescence. Scale bars: 10 m.E) Quantitative analysis of Spry1,
Spry2 and Spry4 mRNA expression by real-time PCR in DRG neurons, treated with NGF (50 ng/ml) during the indicated times. The Sproutys mRNA
levels were normalized using the expression of the housekeeping gene Tbp. Shown are averages 6 SD of triplicate determinations. *p,0.01 versus
control (Ctrl) group (one-way ANOVA followed by Dunnett’s test).
doi:10.1371/journal.pone.0032087.g001
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Spry4, attenuating NGF-induced PC12 cell differentiation
(Supplementary Fig. S4).
Next, we also examined the role of Spry4 on neurite outgrowth
induced by NGF in primary DRG neurons. To this end,
dissociated DRG (E14.5) neurons were transfected with control
or Myc-tagged Spry4 construct together with a GFP expression
vector. In agreement with the results obtained in PC12 cells,
neurite outgrowth stimulated by NGF was significantly reduced in
cells transfected with Myc-Spry4 (neurite length 6 SEM in m,
control: 119.4621.0; Myc-tagged Spry4: 59.664.9, n=6;
*p,0.05) (Fig. 5A, 5B, left histogram and 5C). No differences
were observed in NGF-promoted neuron survival between the two
groups (Fig. 5B, right histogram). Data expressed as average values
6 SEM are as follow: control: 94.164.2; Spry4 vector: 92.063.4,
n=3; p.0.05). These results indicate that inhibition of TrkA
Figure 2. Sprouty4 restricts Erk/MAPK activation in response to NGF. A) Erk2/MAPK activation (Phospho-Erk2/MAPK) was evaluated by
transient transfection of HA-tagged Erk2 plasmid with a control or a Myc-tagged Sprouty4 vector into PC12 cells. After 36 h cells were serum-starved
and stimulated with or without NGF for 10 min. The level of Erk2 activation (P-Erk2) was evaluated by HA-immunoprecipitation followed by
immunoblotting with a specific antibody that recognizes the phosphorylated forms of ERK/MAPK. Reprobing of the same blot with anti-HA and anti-
Myc antibodies is shown. B) Histogram shows quantification of Erk2/MAPK activation. Results are presented as averages 6 SD from three
independent experiments. *p,0.05 (Student’s t test). C) Erk/MAPK activation (P-MAPK) in cell lysates of parental and PC12-Spry4 (Clon S2) cells
treated with NGF (50 ng/ml) and detected by immunoblot (IB). Reprobing of the same blot with anti–tubulin and anti-Myc antibodies is shown. D)
Akt activation (P-Akt) in cell lysates of parental and stable transfected PC12-Spry4 (Clon S2) cells treated with NGF (50 ng/ml) and detected by IB.
Reprobing of the same blot with anti–tubulin and anti-Myc antibodies is shown. E) Ligand-independent Erk/MAPK activation (P-MAPK) was evaluated
by transient transfection of HA-tagged Ras-V12 plasmid (constitutively active Ras) together with a control or a Myc-Sprouty4 vector into PC12 cells.
After 36 h, cells were serum-starved and the levels of Erk/MAPK activation were evaluated by immunoblot with a specific antibody that recognizes
the phosphorylated forms of ERK/MAPK. Reprobing of the same blot with anti-HA, anti-Myc and anti–tubulin antibodies is shown. Fold change
relative to the level of constitutive active HA-Ras V12 is indicated.
doi:10.1371/journal.pone.0032087.g002
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not survival.
Sprouty4 Tyr-53 is essential for its inhibitory activity
To further understand the mechanisms through which Spry4
inhibits NGF signaling, we generated a PC12 cell line expressing
a mutant Spry4 in which tyrosine 53 was substituted by Alanine
(PC12-Spry4-Y53A cells). Interestingly, this tyrosine is con-
served among the four Sprouty family members (see Fig. 6A)
and it was reported to have a dominant negative effect
enhancing trophic factor-dependent Erk/MAPK activation
[12]. To assess the role of this point mutation, parental PC12
and PC12-Spry4-Y53A cells were stimulated with NGF for 10
and 120 min and then Erk/MAPK activation was measured
using anti-phospho-ERK antibodies. As shown in Fig. 6B, PC12
cells expressing Spry4-Y53A showed a substantial increase in
Erk/MAPK activation compared to control cells, indicating that
this Y53A substitution generates a non-functional Spry4 mutant,
that loses its ability to block NGF-dependent Erk/MAPK
pathway.
Then, we investigate the effect of Spry4 Y53A mutant on
NGF-mediated neurite outgrowth. For this purpose, PC12 cells
were transiently transfected with control or Myc-tagged
Sprouty4 Y53A plasmid in combination with an enhanced
GFP. Cells were maintained in the presence of NGF for 72 h
and stained with anti-myc antibodies to confirm that all GFP-
positive cells express Spry4. Overexpression of Spry4 Y53A
could not inhibit NGF-promoted neurite outgrowth, but rather
slightly enhanced it (Fig. 6C, 6D and Supplementary Fig. S3).
However, no tyrosine phosphorylated Spry4 could be detected
after treatment with saturating concentrations of NGF (Supple-
mentary Fig. S5). Taken together, these assays indicate that Tyr-
53 in itself, but not its phosphorylation, is required for Spry4
biological function. Our results are in agreement with previous
data showing that Spry4 could not be tyrosine phosphorylated
upon treatment with serum and different growth factors
including EGF, PDGF, FGF [20].
Figure 3. Sprouty4 restricts Rac1 activation in response to NGF.
A) Rac1 activation (Rac1-GTP) in cell lysates of parental PC12 cells and
clones overexpressing Spry4 (PC12-Spry4 cells) stimulated with NGF
(50 ng/ml) for 10 min. Rac1 activation was assessed by GST-Pak-CRIB
pull-down assay, followed by immunoblot (IB) with anti-Rac1 antibod-
ies. The bottom panels show total Rac1 and Myc-tagged Sprouty4 levels
present in cell lysates. B) Histogram shows quantification of Rac1
activation. Results are presented as averages 6 SEM from three
independent experiments. *p,0.05 (Student’s t test). C) Co-immuno-
precipitation between endogenous Rac1 and Myc-tagged Sprouty4
transiently transfected in Cos cells. Mock and Myc-tagged Sprouty4
transfected cell lysates were immunoprecipitated (IP) with anti-Myc
antibodies. Immunoprecipitated proteins were resolved by SDS-PAGE
and the filters immunoblotted with anti-Rac1 antibodies. The bottom
panel shows equal level of -tubulin in both sample inputs.
doi:10.1371/journal.pone.0032087.g003
Figure 4. Sprouty4 inhibits neuronal differentiation of PC12
cells in response to NGF. A) Photomicrographs show PC12 cells
transfected with control or Myc-tagged Sprouty4 plasmid together with
a GFP expression vector. After 72 h of NGF treatment (50 ng/ml), cells
were fixed and stained with anti-Myc antibodies. Arrowheads indicate
neuronal cell bodies and arrows denote neurite tips. Scale bar: 10 m. B)
Histogram shows quantification of the relative number of GFP positive
PC12 cells bearing neurites longer than 1.5 cell body diameters after
72 h of treatment with NGF. The results are presented as averages SD of
a representative experiment performed in triplicate. *p,0.001 (ANOVA
followed by Student Newman Keuls). The experiment was repeated
three times with similar results.
doi:10.1371/journal.pone.0032087.g004
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response to NGF
An shRNA expression vector directed to the rat Spry4 mRNA
sequence significantly reduced endogenous Spry4 mRNA expres-
sion (Fig. 7A). Furthermore, this Spry4 shRNA vector abolished
the levels of ectopically expressed Spry4 protein in Cos cells
(Fig. 7B). In agreement with a role of Spry4 in the negative control
of TrkA-mediated downstream signaling, Spry4 knockdown
resulted in a substantial increase of MAPK activation in response
to NGF (Fig. 7C). Likewise, a significant potentiation of PC12 cell
differentiation was observed in cells transfected with a rat Spry4
shRNA expression vector and stimulated with NGF for 24 h
(Fig. 7D and E). Remarkably, such levels of differentiation would
not normally be observed in control PC12 cells until after 48–72 h
of NGF treatment.
Discussion
In this study, we provide evidence that Spry4, a NGF-regulated
gene, restricts Erk/MAPK signaling and inhibits Rac1, but not
Akt, activation in response to NGF. At molecular level, we
identified the Spry4 Tyr-53 as an essential determinant for this
inhibitory activity. We also found that Sprouty4 negatively
regulates NGF-induced neuronal differentiation of PC12 cells
and primary sensory neurons. Hence, we propose that Spry4 acts
downstream of TrkA through a negative feedback loop to regulate
neuronal differentiation by inhibiting Erk/MAPK signaling and
Rac1 activation (Fig. 8).
PC12 cells and sensory neurons had provided to be good models
to investigate NGF and FGF-induced neurite outgrowth. While in
the present study, we demonstrate that endogenous Spry4 is a
physiological negative feedback regulator of NGF-induced neuro-
nal differentiation, previous studies proposed Spry2 and Spry4 as
the critical regulators of Erk/MAPK activation related to neuronal
cell differentiation in the context of FGF [12,21].
High-affinity neurotrophin receptors, TrkA, TrkB and TrkC
are expressed in distinct populations of DRG neurons where they
control axonal development, target-innervation and neuronal
survival mediated by NGF, BDNF and NT3, respectively. In
particular, the NGF receptor, TrkA, is expressed in 80% of DRG
neurons during the third embryonic week in rodents and their
proportion drops to 40% postnatally [22]. Since our results
indicate that Spry4 is involved in the differentiation of the TrkA-
positive neuron subpopulation, it remains open the question
whether other sprouty-family members could be modulating
differentiation of other DRG neurons expressing TrkB or TrkC.
The fact that Spry2 and Spry3 have been reported to control
BDNF signaling in central nervous system neurons suggests that
Figure 5. Sprouty4 inhibits neurite outgrowth of dorsal root ganglion neurons (DRG) in response to NGF. A) Dissociated DRG neurons
transfected with GFP in the absence (Control) or in the presence of an excess of Myc-tagged Sprouty4 (Spry4) construct were cultured with NGF
(50 ng/ml). After 36 h in culture, neurons were fixed and stained with anti–tubulin antibodies. Scale bar represents 20 m. Arrows indicate neuronal
cell bodies and arrowheads denote neurite tips. B) Left panel, histogram showing the inhibition of neurite outgrowth in DRG neurons by exogenous
expression of Sprouty4. The results are averages SEM of a representative experiment measured in six wells per experimental group, *, p,0.05
(Student’s t test). The experiment was repeated three times with similar results. Right panel, histogram showing the survival of DRG neurons by
exogenous expression of Sprouty4. Neuronal survival was evaluated using the nuclear staining DAPI. GFP-positive neurons containing fragmented or
condensed nuclear staining were scored as apoptotic cells. The results are averages SEM of a representative experiment performed in triplicate. C)
Histogram shows the distribution of neurons carrying neurites in different length categories after transfection with GFP in the absence (Control) ori n
the presence of Myc-tagged Sprouty4. A total of 43 control- and 40 Sprouty4-transfected neurons from a representative assay were evaluated. Note
the noticeable shift to the left of the distribution of neurons that received the Sprouty4 construct.
doi:10.1371/journal.pone.0032087.g005
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neuronal differentiation by BDNF [8,23].
Sprouty proteins have been shown to attenuate Erk/MAPK
activation induced by a plethora of trophic factors, including FGF,
HGF, VEGF, BDNF and GDNF. However, the molecular points
at which Sprouty proteins disconnect RTK signaling pathways are
still controversial [24]. Hence, even when many reports concluded
that Spry may function downstream RTKs but upstream of Ras
[10,25–27], other studies demonstrated that Spry could inhibit
RTK signaling at the level of Raf1 [28,29].
In particular, mouse Spry4 inhibits VEGF-induced, Ras-
independent ERK/MAPK activation at the level of Raf1, but
has no effect on EGFR-induced, Ras-dependent activation of Raf1
[11,30]. Previous studies demonstrated that NGF activates Erk/
MAPK pathway through a Ras-dependent mechanism [31]. Here,
using a constitutively active Ras construct (V12 Ras), we found
that Spry4 was able to block Ras-dependent Erk/MAPK
activation, indicating that in our system Spry4 acts downstream
Ras, probably at the level of Raf1.
As it was previously observed with FGF and GDNF signaling
[9,12], overexpression of a dominant negative Spry4 Y53A mutant
induced an increase in MAPK activation and cell differentiation in
response to NGF (Fig. 6 B–D and Supplementary Fig. S3).
Together, these dominant negative effects suggest that Spry4
mutant could be inhibiting other endogenous Sproutys forming
homo-and/or hetero-dimers with them. Interestingly, clear
differences in tyrosine phosphorylation of the Sprouty proteins
by a given growth factor were observed. Thus, Spry1 was reported
to be tyrosine phosphorylated by FGF and PDGF, Spry2 by FGF
and EGF, whereas Spry4 was not tyrosine phosphorylated in
response to any of these factors [20]. Consistent with previous
data, we were not able to detect Spry4 tyrosine phosphorylation in
Figure 6. Sprouty4 Y53A mutant loses its ability to block both Erk/MAPK pathway and neurite outgrowth of PC12 cells in response
to NGF. A) Schematic representation of the domain structures of mammalian Sprouty family members. The figure shows an amino acid alignment of
a conserved motif located at the N-terminal half of the molecule. There, a conserved tyrosine residue (Y) is indicated in red. The conserved C-terminal
cysteine-rich domain is also shown. B) Erk/MAPK activation (P-MAPK) in cell lysates of parental and PC12-Myc-Spry4 Y53A cells treated with NGF
(50 ng/ml) and detected by IB with a specific antibody that recognizes the phosphorylated forms of ERK/MAPK. Reprobing of the same blot with
anti–tubulin and anti-Myc antibodies is shown. The experiment was repeated two times with similar results. C) Photomicrographs show PC12 cells
transfected with control or Myc-tagged Sprouty4 Y53A mutant together with a GFP expression vector. After 72 h of NGF treatment, the cells were
fixed and stained with anti-Myc. Arrows indicate neuronal cell bodies and arrowheads denote neurite tips. Scale bar: 10 m. D) The histogram shows
the quantification of the relative number of GFP positive PC12 cells bearing neurites longer than 1.5 cell body diameters after 72 h of treatment with
NGF. The results are presented as averages SD of a representative experiment performed in triplicate. *p,0.05 (ANOVA followed by Student Newman
Keuls). The experiment was repeated three times with similar results.
doi:10.1371/journal.pone.0032087.g006
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Tyr-53 in itself, but not its phosphorylation is required for the
inhibitory activity of Spry4 on NGF signaling.
The regulatory molecules that control the rate of neurite growth
and the signals that determine when and where the axons and
dendrites have to grow are still largely unknown. Interestingly,
Gross et. al (2001) reported that overexpression of Spry1 and Spry2
in PC12 cells blocked neurite outgrowth and branching induced
by NGF [10]. However, these authors failed to detect Spry1 and
Spry2 in PC12 cells even after NGF treatment. This finding
suggests that Spry1 and Spry2 are not physiologically involved in
the morphological differentiation of PC12 cells. Therefore, it
appears likely that other Sprouty family member may be up-
regulated by NGF to control neurite outgrowth. Here, we
characterize Spry4 as a physiological inhibitor of NGF-induced
neurite elongation of PC12 cells and primary DRG neurons.
Endogenous Spry4 expression was rapid and strongly up-regulated
in PC12 cells and DRG neurons upon NGF treatment (Fig. 1). In
contrast, we could not detect up-regulation of Spry1 nor Spry2
mRNAs upon NGF treatment.
Here, we demonstrate that Spry4, restricts neurite outgrowth
induced by NGF without affecting survival. In agreement with
this, Srpy4 was able to block Erk/MAPK and Rac1 but not Akt
signaling pathway in response to NGF. In agreement with our
data, various reports confirmed the role of other Sproutys in the
control of neurite growth and branching induced by neurotrophic
factors, such as FGF, BDNF and GDNF [8,9,12,23]. In these
studies, the authors have also linked the inhibitory effects of Spry2
to the Erk/MAPK pathway. However, Gross et al. have reported
that in differentiated central nervous system neurons overexpres-
sion of Spry2 favored neuronal apoptosis, whereas its downreg-
ulation had a neuroprotective effect [8], suggesting that the
apoptotic cell death might be due to the inhibition of a PI3K/Akt
pathway, which is involved in neuronal survival. Edwin et al.
reported that Spry2 requires the tumor suppressor phosphatase,
PTEN, to inhibit Akt activation induced by the mitogen factor
Figure 7. Knockdown of Sprouty4 potentiates MAPK activation and PC12 cell differentiation in response to NGF. A) Spry4 mRNA levels
were analyzed by real-time PCR in PC12 cells transfected with scrambled (control, Ctrl) or Spry4 shRNA constructs. Transfected cells were enriched by
puromycin treatment in order to increase the population of cells expressing scrambled or Spry4 shRNA constructs. Quantitative analysis is shown as
averages SD of triplicate determinations. The levels of Spry4 mRNA were normalized using the expression of the housekeeping gene Tbp.* p ,0.001
(Student’s t test). B) Spry4 protein levels were analyzed by IB in Cos cells transfected with Spry4 shRNA or a control vector together with Myc-Spry4.
Actin is shown as loading control. C) Spry4 knockdown on Erk2/MAPK activation was analyzed in PC12 cells treated with NGF (50 ng/ml) for 10 min.
Erk2/MAPK activation was evaluated by transient transfection of HA-tagged Erk2 plasmid with a control or Spry4 shRNA construct into PC12 cells. Erk2
activation (P-Erk2) was evaluated by HA-immunoprecipitation (IP) followed by IB with a specific antibody that recognizes the phosphorylated forms
of ERK/MAPK. Reprobing of the same blot with anti-HA antibody is shown. Numbers below the lanes are normalized to the levels of HA-Erk2. D)
Morphological differentiation of PC12 cells transfected with scramble (Ctrl) or Spry4 shRNA cloned in the retroviral vector pGFP-V-RS and treated with
NGF (50 ng/ml) for 24 h. E) The histogram shows the quantification of the relative number of GFP positive neurite-bearing cells longer than 1 or 2 cell
diameters in the different experimental conditions. The results are shown as averages SD of a representative experiment performed in quadruplicates.
*p,0.001 (Student’s t test).
doi:10.1371/journal.pone.0032087.g007
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to anti-proliferative and not to apoptotic effects. Thus, a clear link
between apoptotic cell death and Akt inhibition by Spry2 has not
been demonstrated yet. The fact that Spry2 antagonizes Akt
activation and cell proliferation in response to EGF is consistent
with the increase observed in the number of neurons produced by
the loss of Spry in Drosophila [32]. More recently, Panagiotaki et al
(2010) found that Spry3 also inhibits axonal morphogenesis in vivo
and prevents filopodia formation in spinal cord neurons inhibiting
Ca
2+ signaling pathways activated by BDNF [23]. Remarkably,
Spry3 acts as a very weak inhibitor of Erk/MAPK pathway
downstream of BDNF/TrkB signaling. Thus, Sprouty proteins
seem to behave as specific modulators of different RTK cascades
and not as general inhibitors of RTK-induced MAPK pathway.
Neurite growth is an established marker of neuronal differen-
tiation that requires the coordinated action of different signaling
pathways. Consistent with this, NGF-induced neurite outgrowth
have been reported to require a sustained MAPK activation as
well as activation of Rac1-related pathways that play a key role
regulating cytoskeletal changes. Here, we observed that Spry4
inhibition of TrkA signaling also induces a concomitant reduction
of Rac1 activation. Together, our findings provide an insight into
the mode of action of Spry on neurotrophin signaling and biology.
Work from recent years has revealed that Spry targets are more
diverse than originally assumed [11,19,23,33,34]. In this regards,
the present inhibition of Rac1-related pathways by Spry4 also
contribute to highlight the versatility of this Sprouty family
member to regulate diverse trophic factor-induced signaling
pathways.
Our findings indicate that by modulating Spry4 function, NGF
and TrkA receptors can regulate Rac1 and Erk/MAPK signaling
pathways required for neurite outgrowth. The accurate regulation
of neurotrophin signaling is crucial for the normal development of
the nervous system. In the developing nervous system, neurite
outgrowth is an essential process underlying the formation of
highly specific patterns of neuronal connectivity. Abnormalities in
neurite formation and extension have been speculated to cause
disorganization of neuronal network and eventual neural disor-
ders. Hence, the abnormal expression of Sproutys in different
neuronal types, blocking neurotrophic factor signaling, might be
associated to neurological diseases [35]. Interestingly, mutations in
the Spred1 gene, which codify for a structural and functional
protein related to Sprouty, has been identified in pathologies
characterized by macroencephaly and mental retardation [36,37].
Therefore, further characterization of the mechanisms through
which Sprouty proteins are regulated in neurons may contribute to
understand the underlying causes of many neurodegenerative
diseases and neurological syndromes.
Materials and Methods
Ethics Statement
Animal experiments were approved by Stockholms Norra
djurfo ¨rso ¨ksetiska na ¨mnd (Dnr: 360/06) and by the institutional
animal care and ethichs committee of the Shool of Medicine
(CICUAL-UBA), ethical permit number: 25473/2010.
Cell lines and recombinant proteins
Cos cells were grown in DMEM supplemented with 10% FBS
[38] and neuroblast-like PC12 cells were grown in DMEM
supplemented with 5% horse serum and 10% FBS [18]. NGF was
purchased from Promega. PC12-Sprouty4 cells (clon S2) and
PC12-Sprouty4-Y53A cells (clones S-Y53A-12 and S-Y53A-17)
were generated by stable transfection of the rat pheochromocy-
tome cell line with Myc-tagged mSprouty4 and Myc-tagged
mSprouty4 Y53A mutant respectively. Pak-CRIB was produced
and purified using E.coli BL21, as previously described [18].
Real-Time PCR
The expression of Spry1, Spry2, Spry4 and TATA box binding
protein (Tbp) mRNAs were analyzed. Total RNA was isolated
from PC12 cells and DRG neurons treated with NGF (50 ng/ml)
for different periods of time using RNA-easy columns (Quiagen).
cDNA was synthesized using Multiscribe reverse transcriptase and
random hexamers (Applied Biosystems). The cDNA was amplified
using the following primer sets: TATA box binding protein (Tbp):
forward, 59-GGG GAG CTG TGA TGT GAA GT-39; reverse,
59- CCA GGA AAT AAT TCT GGC TCA-39; Rat Spry1:
forward, 59-AAC AGT GTG GCA AGT GCA AA-39; reverse, 59-
CAC AGG TAT CTG GAG CAG CA-39; Rat Spry2: forward, 59-
TGG CAA GTG CAA GTG TAA GG-39; reverse, 59-ACC ATC
GCG TAC AAC AGT GA-39; Rat Spry4: forward, 59-GCC CAT
TGA CCA GAT GAA GAC-39; reverse, 59-TCC AGT GGC
TTA CAG TGG AC-39.
Real-time PCR was performed using the SYBR Green qPCR
SuperMix (Invitrogen) on an ABI7500 sequence detection system
(Applied Biosystems), according to the manufacturer’s instructions.
Reactions were performed in 25 l volume. Nucleotides, Taq DNA
polymerase, and buffer were included in the LightCycler-DNA
master SYBR Green mix (Invitrogen).
Cell Transfection, Plasmids and pharmacological
treatments
Cos cells were transfected with Polyethylenimine-PEI (Poly-
sciences). PC12 cells were transfected using Fugene-6 (Roche)
following manufacturer’s instructions. Transient transfection of
primary dorsal root ganglion (DRG) neurons was performed using
Lipofectamine 2000 (Invitrogen) in 500 l of DMEM:F12 serum-
free medium containing 1 g of total plasmid DNA (0.2 g of
Figure 8. Model describing the role of Sprouty4 in NGF-
induced TrkA receptor signaling and biology. NGF-TrkA signaling
induces Sprouty4 expression via MAPK pathway. Then, Sprouty4 acting
through a negative feedback loop specifically inhibits MAPK pathway
and Rac1 activation, thereby preventing neuronal differentiation of
PC12 and DRG neurons.
doi:10.1371/journal.pone.0032087.g008
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Sprouty4 or control vector).
Plasmids encoding 6xMyc epitope tag wt-Sprouty4 and the
dominant negative mutant (Y53A-Sprouty4) were kindly provided
by Dr. Akihiko Yoshimura (Kyushu University, Fukuoka, Japan).
Plasmid encoding HA epitope tag Erk2/MAP Kinase was
generously provided by Dr. Jose ´ Marı ´a Rojas (Instituto de Salud
Carlos III, Madrid, Spain). Plasmid encoding GFP was obtained
from Clontech. The plasmid encoding the GST-tagged GTPase
binding domain (GBD) of PAK (PAK-GBD) was kindly provided
by Dr. Hollis T. Cline (Cold Spring Harbor Laboratory, Cold
Spring Harbor, NY, USA). The plasmid encoding the constitutive
active form of H-Ras (HA-Ras-V12) was kindly provided by Dr.
White E. and Dr. Chen J. (The Cancer Institute of New Jersey, NJ,
USA). Pretreatment with the specific MEK inhibitor PD98059
(50 M) was done for 30 min at 37uC before NGF stimulation.
Sensory neuron cultures
Dorsal root ganglion (DRG) neurons, from embryonic day 14.5
(E14.5) Sprague Dawley rats (School of Pharmacy and Biochem-
istry, University of Buenos Aires) were prepared as previously
described [39]. Briefly, the ganglia were dissociated with trypsin
and collagenase, and seeded onto poly-ornithine and laminin
coated plates. The neurons were maintained in DMEM:F12
medium supplemented with 2 mM glutamine, 0.35% bovine
serum albumin, 60 ng/ml progesterone, 16 mg/ml putrescine,
400 ng/ml L-tyroxine, 38 ng/ml sodium selenite, 340 ng/ml
triiodo-thyronine, 60 mg/ml penicillin, 100 mg/ml streptomycin
and NGF (50 ng/ml).
Immunoprecipitation and Western blotting
Cells were lysated at 4uC in buffer containing 0.5% Triton X-
100, 1% -octylglucoside plus protease and phosophatase inhibi-
tors. Protein lysates were clarified by centrifugation and analyzed
by immunoprecipitation and Western blotting as previously
described [38]. The blots were scanned in a Storm 845
PhosphorImager (GE Healthcare Life Sciences), and quantifica-
tions were done with ImageQuant software (GE Healthcare Life
Sciences). Numbers below the lanes indicate fold of induction
relative to control normalized to total levels of the target protein.
The antibodies were obtained from various sources as follows:
anti-phosphotyrosine (p-Tyr), anti-Myc and anti-Sprouty4 (H-100)
were from Santa Cruz Biotechnology, anti-Rac1 was from BD
Biosciences Pharmingen, anti-TrkA was from RnD Systems, anti-
HA antibodies were from Roche, anti-phospho MAPK and anti-
Phospho Akt (Ser 473) were from New England Biolabs and anti-
III-Tubulin was from Promega.
Pull down assays for Rac1 activation
To detect active, GTP-bound Rac1, we performed the pull-
down assay using GST-Pak-CRIB, which specifically binds to
active Rac1 (GTP-bound form). The band intensity in the
immunoblot was quantified, and the levels of Rac-GTP were
normalized to the amount of total Rac1.
Immunofluorescence
Dissociated DRG neurons obtained from E14.5 rat embryos
were fixed with 4% PFA, blocked with 10% donkey serum and
then incubated with polyclonal anti-TrkA (dilution 1/200, R&D
systems), and anti-Sprouty4 (dilution 1/100, Santa Cruz) antibod-
ies. Second antibodies were from Jackson ImmunoResearch.
Photographs were obtained using an Olympus IX-81 inverted
microscope.
Neurite outgrowth assays
For PC12 cell differentiation assays, the cells were transfected
with GFP, GFP plus Myc epitope-tag wt-Sprouty4 or GFP plus
Myc-tag Y53A-Sprouty4 using Fugene-6 reagent in complete
medium. The next day the cells were plated on poly-D-lysine
coated coverslips in 24 multiwell plates and cultured in DMEM
medium supplemented with NGF (50 ng/ml). After 72 h, the cells
were fixed with 4% paraformaldheyde (PFA) and stained with
anti-Myc epitope antibodies. The number of cells bearing neurites
longer than 1.5 cell bodies was quantified relative to the total
number of neurons counted in at least 10 random fields of three
different wells in each experiment. PC12 cell differentiation was
evaluated in three independent experiments. The pictures were
obtained using an Olympus IX-81 inverted microscope.
Neurite outgrowth assays were performed in dissociated cultures
of E14.5 rat DRG neurons. Primary cultures were prepared as
previously described (see above). Neurons were transfected with
GFP plus empty vector (control group) or GFP plus 6xMyc epitope
tag wt-Sprouty4 and cultured in the presence of NGF (50 ng/ml)
for 36 h. Then, cells were fixed with 4% PFA and stained with
anti–tubulin to identify neuronal cells. Neuronal survival was
evaluated using the nuclear stain 49,6 9 –diamino-2-phenylindole
(DAPI) (Invitrogen). GFP-positive neurons containing fragmented
or condensed nuclear staining were scored as apoptotic cells and
not computed in the differentiation assays. Quantification of
neurite length was performed using NIH ImageJ software.
RNAi-mediated knockdown assays
Rat Sprouty4 shRNA (29 mer) and scrambled negative control
plasmids were purchased from Origene (Rockville, MD, USA) and
used according to the manufacturer’s protocols. The retroviral
vector pGFP-V-RS was used for expression of shRNA targeting
rat Spry4. The sequence of the Spry4 shRNA is a 59-GTG CAA
GGT ATC TTC TAC CAC TGT ACT AA-39, and corresponds
to nucleotides 610–638 of rat Spry4. The specificity of Spry4
knockdown was confirmed by real-time PCR and immunoblotting
(IB).
Supporting Information
Figure S1 NGF induces Sprouty4 mRNA expression in
PC12 cells. Semiquantitative RT-PCR analysis (27 cycles) shows
the expression levels of Sprouty4 mRNA at different time-points
after NGF stimulation. The expression level of the housekeeping
gene Tbp was evaluated as an internal control.
(TIF)
Figure S2 Sprouty4 restricts Rac1 activation in re-
sponse to NGF. Rac1 activation (Rac1-GTP) was also evaluated
by transient transfection of PC12 cells with a control (empty
vector) or a Myc-tagged Sprouty4 plasmid. After 36 h, cells were
serum-starved and stimulated with or without NGF (50 ng/ml) for
10 min. Rac1 activation was assessed by GST-Pak-GBD pull-
down assay, followed by immunoblot (IB) with anti-Myc
antibodies to detect transfected Rac1. The bottom panels show
total Rac1 and Myc-tagged Sprouty4 levels present in cell lysates.
(TIF)
Figure S3 Regulation of neuronal differentiation of
PC12-Spry4 and PC12-Spry4 Y53A cell lines in response
to NGF. A) Photomicrographs show parental PC12 cells, clones
overexpressing Myc-tagged Spry4-wt construct (PC12-Spry4 cell
line, clon S2) and cells stably transfected to express Myc-tagged
Sprouty4 Y53A mutant (PC12-Spry4-Y53A cell line, clon S-
Y53A-17). After 72 h of NGF treatment (50 ng/ml), the cells were
Role of Sprouty4 in NGF Signaling
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blue) with DAPI is also shown. Arrowheads indicate neuronal cell
bodies and arrows denote neurite tips. Scale bar: 10 m. B)
Histogram shows quantification of the relative number of PC12
cells bearing neurites longer than 1.5 cell body diameters after
72 h of treatment with NGF. The results are presented as averages
SD of a representative experiment performed in triplicate.
*p,0.05 and **p,0.001 (ANOVA followed by Student Newman
Keuls). The experiment was repeated two times with similar
results.
(TIF)
Figure S4 Rac1-DN mimics the effects of Spry4 on NGF-
induced PC12 cell differentiation. A) Photomicrographs
show PC12 cells co-transfected with either control plasmid or
dominant negative Rac1 (Rac1-DN) construct together with a
plasmid encoding GFP. The cells were stained with DAPI and
rhodamine-conjugated phalloidin. Scale bar represents 10 m.
Arrows indicate cell bodies and arrowheads indicate neurite tips.B)
The histogram shows the quantification of the relative number of
cells bearing neurites longer than 1 cell body diameter after 72 h
of treatment with NGF. The results are presented as average SD of
a representative experiment performed in triplicate. *, p,0.001
(one-way ANOVA, followed by Student-Newman-keuls test).
Similar results were obtained in two independent experiments.
(TIF)
Figure S5 Sprouty4 is not tyrosine phosphorylated in
response to NGF. Left panel, Myc-Spry4 transfected PC12 cells
were treated with NGF at the indicated time points and then, the
cell extracts were immunoprecipitated (IP) with anti-Myc
antibodies followed by immunoblot (IB) with antibodies against
phosphotyrosine (p-Tyr). Reprobing of the same blot with anti-
Myc antibodies is shown. The experiment was repeated three
times with identical results. Right panel, the same cell extracts used
for the analysis of Spry4 phosphorylation were re-precipitated
using anti-TrkA antibodies followed by immunoblot (IB) with
antibodies against phosphotyrosine (p-Tyr) as an internal control
of NGF stimulation and phosphotyrosine detection.
(TIF)
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